# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA3287835 | 34 | pIC50 | = | 5.1 | ALA3295522 | 5.10 | nM | Homo sapiens | |||
2. | ALA3287834 | 31 | pIC50 | = | 5.1 | ALA3295522 | 5.10 | nM | Homo sapiens | |||
3. | ALA3287833 | 29 | pIC50 | = | 6.7 | ALA3295522 | 6.70 | nM | Homo sapiens | |||
4. | ALA3287832 | 27 | pIC50 | = | 5 | ALA3295522 | 5.00 | nM | Homo sapiens | |||
5. | ALA3287828 | 18d | pIC50 | = | 5.4 | ALA3295522 | 5.40 | nM | Homo sapiens | |||
6. | ALA3287827 | 18c | pIC50 | = | 5.9 | ALA3295522 | 5.90 | nM | Homo sapiens | |||
7. | ALA3287826 | 18b | pIC50 | = | 5 | ALA3295522 | 5.00 | nM | Homo sapiens | |||
8. | ALA3287825 | 18a | pIC50 | = | 5.6 | ALA3295522 | 5.60 | nM | Homo sapiens | |||
9. | ALA3287824 | 15 | pIC50 | = | 5.4 | ALA3295522 | 5.40 | nM | Homo sapiens | |||
10. | ALA3287823 | 10 | pIC50 | < | 4.5 | ALA3295522 | nM | Homo sapiens | ||||
11. | ALA3287821 | 9a | pIC50 | = | 6.2 | ALA3295522 | 6.20 | nM | Homo sapiens | |||
12. | ALA3287820 | 8 | pIC50 | < | 4.5 | ALA3295522 | nM | Homo sapiens | ||||
13. | ALA3287819 | 7k | pIC50 | = | 6.3 | ALA3295522 | 6.30 | nM | Homo sapiens | |||
14. | ALA3287817 | 7i | pIC50 | = | 4.6 | ALA3295522 | 4.60 | nM | Homo sapiens | |||
15. | ALA3287814 | 7f | pIC50 | = | 7.4 | ALA3295522 | 7.40 | nM | Homo sapiens | |||
16. | ALA3287813 | 7e | pIC50 | = | 6.9 | ALA3295522 | 6.90 | nM | Homo sapiens | |||
17. | ALA3287811 | 7c | pIC50 | = | 7 | ALA3295522 | 7.00 | nM | Homo sapiens | |||
18. | ALA3287810 | 7b | pIC50 | = | 7.6 | ALA3295522 | 7.60 | nM | Homo sapiens | |||
19. | ALA3287586 | 7a | pIC50 | = | 6.9 | ALA3295522 | 6.90 | nM | Homo sapiens | |||
20. | A2B receptor antagonist 2 | GNF-Pf-1241 | pIC50 | = | 5.3 | ALA3295522 | 5.30 | nM | Homo sapiens |